HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Expand newborn screening using tandem mass spectrometry: two years' experience in Nuevo León, Mexico].

AbstractOBJECTIVE:
To initiate a statewide expanded metabolic screening program in neonates with the purpose of identifying the most common inborn errors of metabolism.
MATERIAL AND METHODS:
From March 2002 through February 2004, a blood sample was obtained between 24 and 48 hours after delivery from every consecutive child born in public hospitals in Nuevo León. It was spotted on filter paper and analyzed by tandem mass spectrometry for expanded metabolic screening.
RESULTS:
A total of 42 264 samples were analyzed. Were obtained seven positive results, one for each disorder: homocystinuria, hyperphenylalaninemia, citrulinemia, transient tyrosinemia, 3-methylcrotonyl CoA carboxylase deficiency, 3-hydroxy-3-methylglutaryl CoA deficiency, and classic galactosemia.
CONCLUSIONS:
The estimated incidence of inborn errors of metabolism is 1:5 000, with a false positive rate of 0.22%. The program permitted the identification of metabolic disorders in the newborn, allowing an early intervention and prevention of life-threatening events and permanent neurological damage.
AuthorsMaría del Rosario Torres-Sepúlveda, Laura E Martínez-de Villarreal, Carmen Esmer, Rogerio González-Alanís, Consuelo Ruiz-Herrera, Alejandra Sánchez-Peña, José Alberto Mendoza-Cruz, Jesús Z Villarreal-Pérez
JournalSalud publica de Mexico (Salud Publica Mex) 2008 May-Jun Vol. 50 Issue 3 Pg. 200-6 ISSN: 1606-7916 [Electronic] Mexico
Vernacular TitleTamiz metabólico neonatal por espectrometría de masas en tándem: dos años de experiencia en Nuevo León, México.
PMID18516367 (Publication Type: English Abstract, Journal Article)
Topics
  • Humans
  • Infant, Newborn
  • Metabolism, Inborn Errors (diagnosis)
  • Mexico
  • Neonatal Screening (methods)
  • Tandem Mass Spectrometry
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: